InvestorsHub Logo
Followers 260
Posts 18187
Boards Moderated 0
Alias Born 01/19/2006

Re: eddie51 post# 78551

Sunday, 10/23/2016 9:20:09 PM

Sunday, October 23, 2016 9:20:09 PM

Post# of 469903
Perhaps a similar approach was just announced by VA for veterans---AD, brain trauma. Vascepa contains 96% EPA, an omega-3 fatty acid also known as icosapent ethyl. It is known to have a powerful anti-inflammatory action:


https://clinicaltrials.gov/ct2/show/NCT02719327?term=Vascepa&rank=1

I wonder what effect this FDA-approved NCE agent, currently sold by Amarin[AMRN], might have in connection with AVXL trials.

See also:

https://dl.dropboxusercontent.com/u/57678878/Compilation%20of%20EPA%20Scientific%20Articles%20.pdf
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News